Mag-aso, Edsel S.
HRN: 19-68-13 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2022
RIFAXIMIN 200MG (TAB)
06/16/2022
06/23/2022
PO
200mg
BID
Imperical Escalation
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Bloodstream Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes